Arthritis Clinical Trials in Sacramento
View 11 new treatments for Arthritis in Sacramento, CA, and nearby areas, such as Elk Grove, Fairfield, Roseville and Vacaville. Every day, Power helps hundreds of arthritis patients connect with leading medical research.Filter Results
Condition
All
How old are you?
Trial Phase
All
Trial Status
All
Adalimumab Discontinuation for Uveitis
Research Clinic, Sacramento + 1 more
The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).Show More
Waitlist
Phase 4
Est. 4 - 6 Weeks
Nisha Acharya, MD MS
Principal Investigator
Non-Surgical Interventions for Knee Osteoarthritis
Research Clinic, Sacramento + 1 more
There is an urgent public health need to reduce reliance on opioids for effective long-term pain management, particularly in knee osteoarthritis (KOA). This effectiveness trial will compare commonly recommended treatments to reduce pain and functional limitations in KOA.These results will lead to improved patient selection for treatment and inform evidence based guidelines by offering well-tested, effective, non-surgical alternatives.Show More
Recruiting
No Placebo Trial
Phase 3
Est. 6 - 12 Weeks
Steven Cohen, MD
Principal Investigator
Deucravacitinib for Psoriatic Arthritis
Bristol-Myers Squibb Clinic, Sacramento + 3 more
This trial is testing a new medication called deucravacitinib to see if it can help people with psoriatic arthritis who haven't tried advanced treatments. The medication works by reducing joint swelling and pain by blocking inflammation. Deucravacitinib is a new oral drug that has shown good results in previous studies for psoriasis.Show More
Waitlist
Phase 3
Est. 6 - 12 Weeks
Bristol-Myers Squibb
Study Director
Amniotic Suspension Allograft for Knee Osteoarthritis
Organogenesis Clinic, Napa + 1 more
This trial is testing if injecting ASA into the knee can help people with knee osteoarthritis feel better. The study will check pain levels, knee function, and safety over several months. ASA (Amniotic Suspension Allograft) has been shown to be an effective treatment for knee osteoarthritis in previous studies.Show More
Recruiting
Phase 3
Est. 3 - 6 Weeks
Unregistered Study Lead
Research Team
Deucravacitinib for Psoriatic Arthritis
Bristol-Myers Squibb Clinic, Sacramento + 2 more
This trial is testing a new medication called deucravacitinib to help people with active Psoriatic Arthritis. It aims to reduce joint pain and swelling by blocking harmful signals in the body. The study includes people who haven't tried biologic treatments or need an alternative to TNFα inhibitors. Deucravacitinib is an emerging treatment option for Psoriatic Arthritis, showing promise in recent studies.Show More
Waitlist
Phase 3
Est. 3 - 6 Weeks
Bristol-Myers Squibb
Study Director
TG-C for Osteoarthritis of the Knee
Kolon TissueGene Clinic, Napa + 1 more
This trial tests TG-C, an injection into the knee, for patients with moderate to severe osteoarthritis. It aims to reduce pain and improve knee function by potentially modifying the disease. TG-C has shown promise in previous studies for managing knee osteoarthritis.Show More
Recruiting
Phase 3
Est. 6 - 12 Weeks
Moon Jong Noh, PhD
Study Chair
Upadacitinib for Rheumatoid Arthritis
AbbVie Clinic, Roseville + 1 more
The purpose of this study was to assess efficacy, including inhibition of radiographic progression, and safety with upadacitinib versus placebo and versus an active comparator, adalimumab, in adults with with moderately to severely active rheumatoid arthritis (RA) who are on a stable background of methotrexate (MTX and who have an inadequate response to MTX.Show More
Waitlist
Phase 3
Est. 3 - 12 Weeks
AbbVie Inc.
Study Director
Amniotic Suspension Allograft for Osteoarthritis
Organogenesis Clinic, Sacramento + 1 more
This trial is testing a new treatment called ASA, which is injected directly into the knee joint. It aims to help patients with knee osteoarthritis by reducing pain and improving joint function. The study will compare the effects of ASA over several months.Show More
Waitlist
Phase 3
Est. 5 - 8 Weeks
Unregistered Study Lead
Research Team
Stem Cell Treatment for Knee Osteoarthritis
Nature Cell Clinic, Napa + 1 more
This trial is testing a new treatment that uses cells from a patient's own fat to help repair knee damage in people with knee osteoarthritis. The cells are injected into the knee to reduce pain and improve joint function. This type of therapy has been increasingly studied and used for treating knee osteoarthritis due to its potential to reduce pain and improve joint function.Show More
Recruiting
Phase 2 & 3
Est. 3 - 12 Weeks
Unregistered Study Lead
Research Team
Afabicin for Bone or Joint Infection
Debiopharm Clinic, Sacramento + 1 more
This is a randomized, active-controlled, open-label study to assess the safety, tolerability and efficacy of Afabicin in the treatment of participants with bone or joint infection due to Staphylococcus aureus \[both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)\] and/or coagulase-negative staphylococci (CoNS) and to compare it to standard of care (SOC).Show More
Recruiting
No Placebo Trial
Phase 2
Est. 4 - 6 Weeks
Unregistered Study Lead
Research Team
Page 1 of 2
Frequently Asked Questions
Explore related conditions